Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Advaxis Inc. (ADXS) Message Board
Search
Search Type
Board
Post
Member
ADXS-First Patient Dosed in Global Phase 3 AIM2CER
Message Board
Public Reply
|
Private Reply
|
Keep
|
Replies
(1)
Post New Msg
Edit Msg
(
) |
Previous
|
Next
Post#
of 171
(Total Views: 4646)
Posted On: 02/06/2017 10:01:39 AM
Posted By:
chemist823
ADXS-First Patient Dosed in Global Phase 3 AIM2CERV Trial for High-risk, Locally Advanced Cervical Cancer.
(0)
(0)
Advaxis Inc. (ADXS) Stock Research Links
ADXS Message Board
Company Profile
Time & Sales
Recent News
Filings
Financials
Buy Rating
Newer
Older
